Prelude Capital Management’s Verona Pharma VRNA Stock Holding History

Prelude Capital Management’s Portfolio VRNA Stock Details VRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-160,565	Closed	-$17.1M	–	1575
2025 Q3	$17.1M	Buy	+160,565	New	+$16.8M	1.34%	3

Other funds holding VRNA

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

Prelude Capital Management's VRNA Position: Q4 2025 in Review

Prelude Capital Management sold out of Verona Pharma (VRNA) in Q4 2025, closing a stake of 160,565 shares — an estimated $17.1M sold.

Prelude Capital Management first reported a position in VRNA in Q3 2025 and held it in 1 quarter. The position peaked at $17.1M in Q3 2025. 1 fund tracked by Wall St. Rank holds VRNA as of Q4 2025.

Prelude Capital Management reported no remaining Verona Pharma position as of Q4 2025 after selling out during the quarter.
Prelude Capital Management sold 160,565 Verona Pharma shares in Q4 2025, an estimated $17.1M.
Prelude Capital Management first reported a position in Verona Pharma in Q3 2025 and held it in 1 quarter.
Prelude Capital Management's Verona Pharma position peaked at $17.1M in Q3 2025.
1 fund tracked by Wall St. Rank held Verona Pharma as of Q4 2025.

Based on Prelude Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.